AN2 Therapeutics, Inc.
ANTX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001880438
In the last 90 days, AN2 Therapeutics, Inc. insiders filed 1 open-market purchase and 5 sales; 66 institutions reported holding it in 13F filings for Q2 2026, worth $119.0M in total; no superinvestor holds it.
13F holders, Q1 2025
Institutional positions in AN2 Therapeutics, Inc. as of Mar 31, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 38
- 0 vs. Q4 2024
- Shares held
- 14.3M
- −188.1K (−1.3%) vs. Q4 2024
- Total value
- $19.5M
- −$546.4K (−2.7%) vs. Q4 2024
- New holders
- 5
- 8 more added
- Sold out
- 5
- 11 more reduced
Compare with Q4 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ANTX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 66 | $119.0M |
| Q1 2026 | 52 | $74.8M |
| Q4 2025 | 38 | $9.88M |
| Q3 2025 | 36 | $10.5M |
| Q2 2025 | 37 | $8.78M |
| Q1 2025 | 38 | $19.5M |
| Q4 2024 | 38 | $20.1M |
| Q3 2024 | 31 | $14.5M |
| Q2 2024 | 45 | $41.7M |
| Q1 2024 | 54 | $60.9M |
| Q4 2023 | 51 | $417.9M |
| Q3 2023 | 37 | $320.3M |
| Q2 2023 | 31 | $99.9M |
| Q1 2023 | 38 | $94.8M |
| Q4 2022 | 36 | $92.9M |
| Q3 2022 | 38 | $165.1M |
| Q2 2022 | 36 | $72.4M |
| Q1 2022 | 18 | $134.1M |
| Q4 2021 | 0 | $0 |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q1 2025
Shares, value and share of portfolio for each institution holding AN2 Therapeutics, Inc.; share changes are against Q4 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| BML Capital Management, LLC | 5,749,432 | $7.82M | 6.33% | 00.0% | Unchanged |
| Almitas Capital LLC | 1,313,111 | $1.79M | 0.59% | 00.0% | Unchanged |
| Vanguard Group Inc | 1,035,947 | $1.41M | 0.00% | 00.0% | Unchanged |
| Adage Capital Partners GP, L.L.C. | 1,000,000 | $1.36M | 0.00% | +687,385+219.9% | Added |
| Pfizer Inc | 715,295 | $972.8K | 0.19% | 00.0% | Unchanged |
| Peapod Lane Capital LLC | 580,853 | $790.0K | 0.89% | +2,028+0.4% | Added |
| Bank of Nova Scotia | 459,194 | $624.5K | 0.00% | +64,326+16.3% | Added |
| Two Sigma Advisers, LP | 445,004 | $605.2K | 0.00% | −83,296−15.8% | Reduced |
| Bank of Montreal | 422,077 | $574.0K | 0.00% | 00.0% | Unchanged |
| Aldebaran Capital, LLC | 406,623 | $553.0K | 0.52% | +62,939+18.3% | Added |
| Bank of America Corp | 385,483 | $524.3K | 0.00% | +80.0% | Added |
| Renaissance Technologies LLC | 368,708 | $501.4K | 0.00% | −211,065−36.4% | Reduced |
| Two Sigma Investments, LP | 343,960 | $467.8K | 0.00% | −56,372−14.1% | Reduced |
| BlackRock, Inc. | 300,686 | $408.9K | 0.00% | −735−0.2% | Reduced |
| Geode Capital Management, LLC | 253,923 | $345.4K | 0.00% | +26,127+11.5% | Added |
| UBS Group AG | 106,021 | $144.2K | 0.00% | −64,271−37.7% | Reduced |
| State Street Corp | 87,002 | $118.3K | 0.00% | 00.0% | Unchanged |
| Bridgeway Capital Management, LLC | 59,900 | $81.5K | 0.00% | −102,300−63.1% | Reduced |
| Millennium Management LLC | 50,038 | $68.1K | 0.00% | −159,328−76.1% | Reduced |
| Rangeley Capital, LLC | 50,000 | $68.0K | 0.08% | +50,000 | New |
| Northern Trust Corp | 43,196 | $58.7K | 0.00% | 00.0% | Unchanged |
| Integrated Wealth Concepts LLC | 25,000 | $34.0K | 0.00% | 00.0% | Unchanged |
| Lepercq De Neuflize Asset Management LLC | 23,234 | $31.6K | 0.03% | +23,234 | New |
| Private Advisor Group, LLC | 22,500 | $30.6K | 0.00% | 00.0% | Unchanged |
| Schonfeld Strategic Advisors LLC | 20,115 | $27.4K | 0.00% | −6,785−25.2% | Reduced |
| Inspirion Wealth Advisors, LLC | 18,950 | $25.8K | 0.00% | +18,950 | New |
| Jane Street Group, LLC | 18,131 | $24.7K | 0.00% | +18,131 | New |
| Federated Hermes, Inc. | 12,237 | $16.6K | 0.00% | +4,745+63.3% | Added |
| Qube Research & Technologies Ltd | 10,184 | $13.8K | 0.00% | −10.0% | Reduced |
| Captrust Financial Advisors | 10,000 | $13.6K | 0.00% | −18,667−65.1% | Reduced |
| Tower Research Capital LLC (TRC) | 2,082 | $2.83K | 0.00% | +619+42.3% | Added |
| Innovative Advisory Group, LLC | 1,170 | $1.59K | 0.00% | 00.0% | Unchanged |
| Coldstream Capital Management Inc | 783 | $1.06K | 0.00% | +783 | New |
| BNP Paribas Arbitrage, SA | 312 | $424 | 0.00% | 00.0% | Unchanged |
| Morgan Stanley | 300 | $408 | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 300 | $408 | 0.00% | 00.0% | Unchanged |
| SBI Securities Co., Ltd. | 200 | $272 | 0.00% | 00.0% | Unchanged |
| JPMorgan Chase & Co | 49 | $67 | 0.00% | −3−5.8% | Reduced |
| Stonepine Capital Management, LLC | 0 | $0 | 0.00% | −196,732−100.0% | Sold out |
| Marquette Asset Management, LLC | 0 | $0 | 0.00% | −83,206−100.0% | Sold out |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −67,994−100.0% | Sold out |
| Squarepoint Ops LLC | 0 | $0 | 0.00% | −62,441−100.0% | Sold out |
| XTX Topco Ltd | 0 | $0 | 0.00% | −34,179−100.0% | Sold out |